JD Health

JD Health, founded in 2018, operates as a prominent pharmaceutical products e-commerce platform and a key subsidiary of JD.com. Headquartered in Beijing, China, the company specializes in the retail pharmacy sector, leveraging advanced logistics and digital infrastructure to provide comprehensive healthcare solutions. As a publicly traded entity under the ticker HKEX: 6618, JD Health maintains a significant market presence within the competitive landscape of online drug stores and retail pharmacy services.

The organization currently supports a workforce of 1,000-5,000 employees, facilitating operations across its primary location. By integrating pharmaceutical supply chain management with consumer-facing digital platforms, JD Health optimizes the delivery of medical products and health services. The company’s business model focuses on scaling e-commerce capabilities to meet the growing demand for accessible healthcare, positioning itself as a leader in the digital health transformation within the Asian market.

JD Health has demonstrated robust growth through strategic capital infusions, including a notable Series B funding round of $0.8B in 2020 and a subsequent stock issuance of $3.5B later that year. These financial milestones underscore the company's capacity for sustained expansion and operational excellence. Explore financial highlights to review the detailed fiscal performance and market metrics that define the company's current trajectory in the pharmaceutical retail industry.